Larvol Delta - Black-Diamond-Therapeutics-Reports-Second-Quarter-2023-Financial-Results-and-Provides-Corporate-Update

tuxobertinib (BDTX-189) - Black Diamond Therap

BDTX-4933 - Black Diamond Therap

BDTX-1535 - Black Diamond Therap

https://www.globenewswire.com/news-release/2023/08/11/2723463/0/en/Black-Diamond-Therapeutics-Reports-Second-Quarter-2023-Financial-Results-and-Provides-Corporate-Update.html

Aug 11, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next